Merck & Company, Inc. (NYSE:MRK) was upgraded by equities research analysts at Vetr from a “sell” rating to a “hold” rating in a report issued on Wednesday. The firm presently has a $63.44 target price on the stock. Vetr‘s price objective would indicate a potential downside of 2.83% from the company’s current price. MRK has […]
